This independent HPLC lab test with UV detection coupled with mass spectrometry confirms Cartalax 20mg from Pura Peptide at 97.66% purity. The analysis was conducted by SafeCert Labs on April 25, 2025.
Cartalax is a peptide compound researched for its potential role in cartilage health and joint function support. A purity level of 97.66% indicates minimal contamination and high-grade synthesis.
The full certificate of analysis is available for download on this page.

Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.